home / stock / zlab / zlab news


ZLAB News and Press, Zai Lab Limited From 08/07/25

Stock Information

Company Name: Zai Lab Limited
Stock Symbol: ZLAB
Market: NASDAQ
Website: zailaboratory.com

Menu

ZLAB ZLAB Quote ZLAB Short ZLAB News ZLAB Articles ZLAB Message Board
Get ZLAB Alerts

News, Short Squeeze, Breakout and More Instantly...

ZLAB - Zai Lab GAAP EPS of -$0.37 beats by $0.05, revenue of $110M misses by $15.02M

2025-08-07 06:07:40 ET More on Zai Lab Zai Lab Limited Is Well Positioned For Long-Term Growth Zai Lab Limited: Banking On Chinese Pharma Growth Zai Lab Limited (ZLAB) Q1 2025 Earnings Call Transcript Zai Lab Q2 2025 Earnings Preview Amgen, Zai Lab su...

ZLAB - Expected earnings - Zai Lab Limited

Zai Lab Limited (ZLAB) is expected to report $-0.37 for Q2 2025

ZLAB - ZLAB - Historical Price Movements Surrounding Earnings

2025-08-06 18:45:22 ET Zai Lab Limited (ZLAB) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 4.09%. The average open to low on the day of earnings was -6.07%. The average open to close ...

ZLAB - ZLAB - Historical Earnings Price Analysis

2025-08-06 18:40:21 ET Zai Lab Limited (ZLAB) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in ZLAB stock price following earnings has averaged ±7.07% , with a median of 4.97%. The ...

ZLAB - Zai Lab Q2 2025 Earnings Preview

2025-08-06 12:17:24 ET More on Zai Lab Zai Lab Limited Is Well Positioned For Long-Term Growth Zai Lab Limited: Banking On Chinese Pharma Growth Zai Lab Limited (ZLAB) Q1 2025 Earnings Call Transcript Amgen, Zai Lab succeed in gastric cancer study Zai...

ZLAB - Baron Emerging Markets Fund Q2 2025 Shareholder Letter

2025-08-06 09:24:00 ET Dear Baron Emerging Markets Fund Shareholder: Baron Emerging Markets Fund ® (the Fund) gained 15.39% (Institutional Shares) during the second quarter of 2025, while its primary benchmark, the MSCI Emerging Markets Index (the Benchmark), appreciated 11...

ZLAB - AstraZeneca succeeds in late-stage trial for myasthenia gravis therapy

2025-07-24 08:27:12 ET More on AstraZeneca AstraZeneca: Just What The Doctor Ordered AstraZeneca: Navigating Challenges Across Geographies Well AstraZeneca: Fascinating Company With Lofty Ambitions - Just Not A Buy Yet RFK Jr. formally orders removal of thime...

ZLAB - ClearBridge International Growth ACWI Ex-US Strategy Q2 2025 Commentary

2025-07-18 10:00:00 ET By Elisa Mazen | Michael Testorf, CFA | Pawel Wroblewski, CFA Tailwinds Accelerate for Overseas Equities - Market Overview International equities maintained positive momentum in the second quarter as Europe signaled progress on fiscal stimulus and refo...

ZLAB - Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities

Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities Canada NewsWire Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER. BC , July 16, 2025 /CNW/ -- As lawmakers weigh poten...

ZLAB - Zai Lab to Announce Second Quarter 2025 Financial Results and Recent Corporate Updates on August 7, 2025

- Company to host conference call and webcast on August 7, 2025, at 8:00 a.m. ET (8:00 p.m. HKT) Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report its second quarter 2025 financial results and provide recent corporate updates on August 7, 2025, before th...

Previous 10 Next 10